review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.AUTREV.2009.11.003 |
P698 | PubMed publication ID | 19906362 |
P50 | author | Brigitte Ranque | Q57422100 |
P2093 | author name string | Luc Mouthon | |
P433 | issue | 5 | |
P304 | page(s) | A311-8 | |
P577 | publication date | 2009-11-10 | |
P1433 | published in | Autoimmunity Reviews | Q15754966 |
P1476 | title | Geoepidemiology of systemic sclerosis | |
P478 | volume | 9 |
Q38648592 | An overview of environmental risk factors in systemic sclerosis |
Q34024573 | Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome? |
Q33825348 | Autoimmunity and environment: am I at risk? |
Q26998770 | Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies |
Q37841101 | Celiac disease: a model disease for gene-environment interaction |
Q37385700 | Comparative analysis of educational needs of patients with rheumatic diseases selected based on the Polish version of the Educational Needs Assessment Tool (Pol-ENAT). |
Q33857158 | Compensation for occupational skin diseases |
Q37102484 | Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study |
Q38823948 | Current and future direction in the management of scleroderma. |
Q37877594 | Cutting edge issues in rheumatic fever |
Q45959876 | Cutting-edge issues in organ-specific autoimmunity. |
Q37905783 | Deciphering the genetic background of systemic sclerosis |
Q50683587 | Early identification of vascular damage in patients with systemic sclerosis |
Q35674181 | Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis |
Q38071978 | Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis |
Q28390922 | Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop |
Q92003078 | Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease |
Q42558630 | Explosion of autoimmune diseases and the mosaic of old and novel factors |
Q34363942 | Factors associated with development of gastrointestinal problems in patients with scleroderma: a protocol for a systematic review |
Q28077405 | Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review |
Q93090532 | Factors associated with quality of life in systemic sclerosis: a cross-sectional study |
Q35827986 | Gender differences in autoimmunity associated with exposure to environmental factors |
Q37958780 | Genetics of systemic sclerosis: an update |
Q45932087 | Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. |
Q87866606 | High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis |
Q92263552 | High risk of gastrointestinal hemorrhage in patients with systemic sclerosis |
Q41035757 | Home parenteral nutrition is beneficial in systemic sclerosis patients with gastrointestinal dysfunction |
Q60947878 | Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis |
Q40446240 | Hyperbaric oxygen therapy for chronic ulcers in systemic sclerosis - case series |
Q51835838 | Immune-Mediated Heart Disease. |
Q39332233 | Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil |
Q48362710 | Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study |
Q45007419 | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis |
Q38304255 | Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future |
Q90697873 | Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016 |
Q83082263 | Mechanisms and pathophysiology of autoimmune disease |
Q40696023 | Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012. |
Q57801056 | Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China |
Q28658168 | Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells |
Q37864261 | Recommendations for the care of oral involvement in patients with systemic sclerosis |
Q90354031 | Renal pathology and clinical associations in systemic sclerosis: a historical cohort study |
Q45245990 | Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors |
Q30458135 | Role of 2D strain in the early identification of left ventricular dysfunction and in the risk stratification of systemic sclerosis patients |
Q42371336 | Swallowing difficulties with medication intake assessed with a novel self-report questionnaire in patients with systemic sclerosis - a cross-sectional population study |
Q38694173 | Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort |
Q84974441 | The Persistent Challenge of Lupus Nephritis |
Q58705720 | The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy |
Q41673061 | The economic burden and health-related quality of life associated with systemic sclerosis in France |
Q43786536 | The future of autoimmunity |
Q37967566 | The therapeutic potential of epigenetics in autoimmune diseases. |
Q92464838 | Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study |
Q37973287 | Unraveling the genetic component of systemic sclerosis |
Search more.